Free Information Kit

Learn more about living with lupus and treatment with BENLYSTA

Already taking BENLYSTA?

Get ongoing support for your treatment journey.

Expand to watch videos from
real lupus patients taking BENLYSTA.

The BENLYSTA® Co-pay Program

$0 Co-pay for eligible patients

If you are approved for the BENLYSTA Co-pay Program, we will pay 100% of your out-of-pocket costs for BENLYSTA up to a total of $9,000 annually. This does not cover the cost of your doctor's office visits or administration of BENLYSTA.

Who is eligible?

The BENLYSTA Co-pay Program is for people:

  • who have commercial insurance (not a state or federal health insurance plan like Medicare or Medicaid), or
  • whose insurance does not provide coverage for BENLYSTA, or
  • are uninsured

Enrollment in the program is simple.

  • Complete the enrollment form. When you're prescribed BENLYSTA, you may receive an enrollment form from your healthcare professional. If you do not, you can download the form here. Be sure that both you and your doctor sign the form. Learn more about completing the form here
  • Fax the form. Fax the completed form to BENLYSTA Gateway at 1-877-850-9901. Please call BENLYSTA Gateway at 1-877-4-BENLYSTA (1-877-423-6597) if you have any questions.
  • Confirm your eligibility. A trained BENLYSTA Gateway specialist will review your enrollment form. The Specialist will follow up with you and your doctor to let you know if you qualify.

BENLYSTA Gateway
1-877-4-BENLYSTA

(1-877-423-6597)
Monday through Friday, 8 AM to 8 PM Eastern Time

Real answers from
a real person

Call the BENLYSTA┬« Gateway toll-free Monday-Friday 8AM – 8PM EST at 1-877-4-BENLYSTA (1-877-423-6597)

What Is BENLYSTA?

BENLYSTA is a prescription medication used to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.

It is not known if BENLYSTA is safe and effective in people with severe active lupus nephritis or severe active central nervous system lupus, and it has not been studied in combination with other biologics or intravenous cyclophosphamide. Use of BENLYSTA is not recommended in these situations.

Important Safety Information

The most important information to know about BENLYSTA:

BENLYSTA can cause serious side effects. Some of these side effects may cause death. It is not known if BENLYSTA causes these serious side effects.

Important Safety Information

The most important information to know about BENLYSTA:

BENLYSTA can cause serious side effects. Some of these side effects may cause death. It is not known if BENLYSTA causes these serious side effects.

Tell your healthcare professional right away if you have any of the symptoms listed below while receiving BENLYSTA

Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.

Before receiving BENLYSTA also discuss with your healthcare professional if you:

Women of childbearing age should use adequate birth control measures while taking BENLYSTA and for at least four months after their final treatment with BENLYSTA.

Remember to tell your healthcare professional about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Possible side effects of BENLYSTA

The most common side effects of BENLYSTA include:

Tell your healthcare professional if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of BENLYSTA. For more information, ask your healthcare professional.

Other Important Information

In 2 of 3 studies, fewer blacks/African Americans who received BENLYSTA responded to treatment compared to blacks/African Americans who did not receive BENLYSTA. Therefore, caution should be used when considering treatment with BENLYSTA in blacks/African Americans. It is important to discuss with your healthcare professional whether BENLYSTA is right for you. A clinical trial is ongoing to study BENLYSTA specifically in blacks/African Americans with lupus.


For more information, call the BENLYSTA® Gateway at 1-877-4-BENLYSTA (1-877-423-6597)
Monday through Friday, 8 AM to 8 PM Eastern Time.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.